Effectiveness of Messenger RNA Vaccines against SARS-CoV-2 Infection in Hemodialysis Patients: A Case–Control Study
Patients with end-stage kidney disease (ESKD) are at increased risk for SARS-CoV-2 infection and its complications compared with the general population. Several studies evaluated the effectiveness of COVID-19 vaccines in the dialysis population but showed mixed results. The aim of this study was to...
Main Authors: | Mohamad M. Alkadi, Abdullah Hamad, Hafedh Ghazouani, Mostafa Elshirbeny, Mohamed Y. Ali, Tarek Ghonimi, Rania Ibrahim, Essa Abuhelaiqa, Abdul Badi Abou-Samra, Hassan Al-Malki, Adeel A. Butt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/1/49 |
Similar Items
-
From past to present: Exploring COVID-19 in Qatar’s hemodialysis population across Omicron dominant and pre-Omicron periods
by: Abdullah Hamad, et al.
Published: (2023-01-01) -
From past to present: Exploring COVID-19 in Qatar's hemodialysis population across Omicron dominant and pre-Omicron periods.
by: Abdullah Hamad, et al.
Published: (2023-01-01) -
Two Years’ Experience of Intensive Home Hemodialysis with the Physidia S<sup>3</sup> System: Results from the RECAP Study
by: Hafedh Fessi, et al.
Published: (2023-02-01) -
Femoral tunneled hemodialysis catheter as a permanent access for hemodialysis patients
by: Assem M Herzallah, et al.
Published: (2018-01-01) -
Is the cost of the new home dialysis techniques still advantageous compared to in-center hemodialysis? An Italian single center analysis and comparison with experiences from western countries
by: Gian Maria Iadarola, et al.
Published: (2024-03-01)